Re-appointment of M/s. Lavanya & Associates as the Cost Auditors for FY 2026-27.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare held its Board meeting on May 23, 2026 and approved multiple items. The company reported audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026 with an unmodified opinion from statutory auditors S.R. Batliboi & Associates LLP. The Board recommended a final dividend of Rs 3.5 per share (35% on face value) for FY 2025-26, subject to shareholder approval at the 28th AGM scheduled for July 29, 2026. Key director re-appointments include Dr. Ramesh Kancharla as Chairman and Managing Director, Dr. Dinesh Kumar Chirla as Whole Time Director, and renewal of independent director terms for Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati. The cost auditor M/s. Lavanya & Associates LLP was re-appointed for FY 2026-27.
This is a routine governance filing with no negative signals. The company delivered clean financials and continuity in leadership with shareholder-friendly dividend recommendation. The simultaneous re-appointments of multiple directors and auditors indicate stable governance.